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Boron-rich, cytocompatible block copolymer
nanoparticles by polymerization-induced
self-assembly†
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Core–shell nanoparticles (NPs) with a boron-rich core were syn-
thesized by RAFT-mediated polymerization-induced self-assembly
using a new methacrylic boronate ester monomer. Under specific
conditions, sub-100 nm spherical NPs could be obtained at high
conversions by either emulsion or dispersion RAFT polymerization
using poly(oligo(ethylene glycol) methacrylate) (POEGMA) dithio-
benozate-based chain transfer agents. Phenylboronic acid surface-
functionalized NPs were obtained using a telechelic POEGMA.
Primary data on biocompatibility is provided and suggests suit-
ability as boron delivery agent for boron neutron capture therapy.
Among the various potential techniques to fight cancer and
eliminate tumor cells, boron neutron capture therapy (BNCT)
is an attractive binary treatment based on (i) delivery of non-
toxic boron drugs into tumor cells and (ii) irradiation with a
thermal neutron beam to trigger nuclear fission of boron-10
and subsequent production of high-energy alpha particles.1
The key challenge for successful BNCT treatment is the
specific accumulation of boron – in any form – in tumor cells.
Boronophenylalanine (BPA) has been one of the two major
compounds used in BNCT clinical trials for decades, yet
requires rather large injected amounts to reach sufficient
boron concentrations.2 The low tumor uptake and selectivity,
and short retention of BPA are due to its non-selective tumor-
targeting functionality, negative charge, and low molecular
weight.3 Similar issues are encountered with the other major
compound used in BNCT, namely sodium borocaptate. To
improve the longer circulation of boron agents and therefore
facilitate specific tumor accumulation, several types of nano-
particles (NPs) such as liposome, dendrimer, and block copoly-
mer (BCP) NPs have been evaluated as potential delivery
system.4 For instance, boronic acid-containing BCP NPs have
been designed and synthesized for BNCT.5–10 In these
examples, boron compounds were either encapsulated in or co-
valently linked to nanoparticles supposed to accumulate in
neoplastic regions via the enhanced permeability and reten-
tion (EPR) effect.11,12 While they may improve specific delivery,
macromolecular approaches to boron delivery for BNCT still
exhibit shortcomings such as low boron content per unit
weight, and/or complicated and time-consuming particle syn-
thesis. In the present contribution, we sought to harness
polymerization-induced self-assembly (PISA) to prepare boron-
rich nanoparticles because this method precisely addresses
such shortcomings.
PISA has become a very popular method over the last
decade to design core–shell polymeric NPs with specific
shapes and controlled diameters.13–17 Indeed, PISA not only
yields colloidal suspensions with homogeneous morphology
directly at high concentrations, but also simultaneously gives
access to precise macromolecular architecture with high
control over functionality,18,19 with excellent potential for a
range of applications.20–27 We thus anticipated that the PISA-
based synthesis of nanoparticles with a boron-rich core and a
biocompatible shell in a time-efficient manner could be poss-
ible. Note that, while boron-containing polymers have recently
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been in vogue,28–30 no example of boron-containing PISA-
made nanomaterials can be found. To this end, we designed a
new boronate ester-functionalized methacrylate based on a
benzyl methacrylate (BzMA) scaffold – a monomer well-known
in the PISA realm – and polymerized it in polar media under
radical initiation in the presence of a poly(oligo(ethylene
glycol) methacrylate) (POEGMA) macromolecular chain trans-
fer agent (macroCTA). POEGMA was selected for its high solu-
bility in a wide range of solvents, as well as its biocompatibility
and propensity to provide a stealth character to coated nano-
materials, thereby enabling application of our NPs as nanome-
dicines, hence in the BNCT field.31–33 Moreover, since the
POEGMA macroCTA is synthesized by reversible addition–frag-
mentation transfer (RAFT) polymerization, α-functionalized
POEGMA macroCTAs can be readily obtained, which allows a
straightforward post-functionalization on the surface of nano-
particles, e.g., for targeted delivery. Here, phenylboronic acid
was introduced as α end group for specific targeting of sialy-
lated epitopes on the membrane of solid tumors.34 The overall
design of the present study is displayed in Scheme 1.
As mentioned above, we designed the boronate ester-con-
taining methacrylate based on BzMA because the latter was
successfully employed in multiple RAFT polymerization-
induced self-assembly (RAFTPISA) studies.35–39 We chose the
ester form of boronic acid to prevent potential issues related to
self-dimerization and subsequent uncontrolled crosslinking
during synthesis,40,41 as well as to tune solubility with regards
to the PISA process.16 4-Pinacolboronylbenzyl methacrylate
monomer PBBMA was synthetized in two steps: (i) esterifica-
tion of commercially available 4-(hydroxymethyl) phenyl-
boronic acid with pinacol and (ii) Steglich esterification with
methacrylic acid (see ESI†). Combination of 1H, 13C, and 11B
NMR spectroscopy and high-resolution mass spectrometry
characterizations confirmed structure and purity of PBBMA,
obtained as an oil (Fig. S1–S4†). Before implementing it for
the synthesis of amphiphilic block copolymers in dispersed
media, the propensity of this monomer to be polymerized by
RAFT solution polymerization with a low-molar-mass CTA,
namely 2-cyano-2-propyl benzodithioate (CPBD), was first
assessed. The polymerization was conducted in N,N-dimethyl-
acetamide (DMAc) at various [PBBMA]/[CPBD] ratios (100, 200,
and 400) with a constant [AIBN]/[CPBD] ratio equal to 0.2, at
either 0.3 M or 0.6 M of PBBMA (9 and 18 wt%, respectively).
As expected, the higher concentration of monomer led to a
faster polymerization (Fig. 1A). In most cases, the polymeriz-
ation fulfilled elementary criteria for a controlled/living
polymerization, i.e., linear increase in pseudo-first order plot –
at least in the first 8 hours of polymerization, linear increase
of number-average molar mass with conversion, and clear
shift of size-exclusion chromatography (SEC) traces (Fig. 1 and
S5†). However, it was possible to achieve high conversions in a
reasonable time frame only at the lowest targeted degree of
polymerization (DPth = 100), i.e., at the highest CPBD and
AIBN concentrations. Higher DPth systematically involved
higher Đ values. Nevertheless, PBBMA showed a sufficient
amenability to polymerize via the RAFT process and was sub-
sequently used in emulsion and dispersion polymerizations,
without surfactant, in the presence of POEGMA macroCTAs.
A set of macroCTAs was prepared by RAFT solution
polymerization of two distinct OEGMA oligomonomers (Mn =
300 or 500 g mol−1) with either CPBD or an
N-hydroxysuccinimide ester derivative of CPBD, to introduce α
functionality, which should then eventually be presented at
the particle surface after RAFTPISA (see Scheme 1). All
macroCTAs were obtained with low dispersity (Đ < 1.2)
(Table S1†).
First, we examined the emulsion polymerization of PBBMA
in water/EtOH (3 : 1 vol/vol). All sets of conditions can be
found in Table S2.† For this series, POEGMA500 was chosen for
its high water solubility (even at high temperatures), which is a
vital parameter in PISA. For instance, emulsion RAFTPISA at
70 °C with [PBBMA]/[POEGMA500]/[ACVA] = 100/1/0.2 at 10 wt%
solids content (Table S2,† entry 1) led to about 60% conversion
after 2 h with a reasonably narrow molar mass distribution
(MMD), yet did not significantly proceed further (Fig. S8†).
The resulting NPs were stable monodisperse spheres of about
50 nm, as determined by dynamic light scattering (DLS)
(Fig. S9†), accompanied by a slight coagulum. Increase in total
solids content to 20 wt% allowed higher PBBMA conversions
to be reached (94% in 2 h; Table S2,† entry 4), yet with a broad-
Scheme 1 Synthetic route and compounds employed in the current study for boron-rich nanoparticle formation by RAFT polymerization-induced
self-assembly (RAFTPISA). ACVA = 4,4’-azobis(4-cyanopentanoic acid). AIBN = azobisisobutyronitrile.
Polymer Chemistry Communication


























































































ening of the MMD (Fig. 2A). Although the final dispersion con-
tained a homogeneous population of spheres of around
50 nm, as observed by transmission electron microscopy
(TEM) (Fig. 2B) and DLS (Fig. S10†), a small amount of coagu-
lum was again present. Increasing [PBBMA]/[POEGMA500] to
200 or 400 at solids contents of 10 or 20 wt% systematically led
to early destabilization and low conversions (entries 2, 3, 5,
and 6, Table S2†).
In order to produce a colloidally stable PISA system and
achieve easy removal of potentially unreacted monomer, we
turned to a dispersion process. Methanol was chosen as
polymerization medium because (i) PBBMA was found to be
highly soluble in it as opposed to its polymer – which is a
requirement for PISA – and (ii) because it is considered a
green solvent.42 As the thermoresponsive character of
POEGMAs with shorter oligoethylene glycol side chains
becomes irrelevant in methanol, we chose to start our investi-
gation on dispersion RAFTPISA with POEGMA300, because this
is also a more practical polymer in terms of purification (i.e.,
separation of residual monomer). A series of experiments was
performed by varying DPth (100, 200, and 400) and the total
solids content (10, 15, and 30 wt%). With the previously
employed [initiator]/[CTA] ratio of 0.2, far-from-complete
monomer conversions were obtained after 24 h (Table S3,
entries 1–6, as well as Fig. S11†). Increasing [initiator]/[CTA] to
0.5 allowed a nearly full PBBMA conversion for DPth = 100 at
15 and 30 wt%. In those cases, as well as for DPth = 200 at
30 wt%, more than 90% PBBMA was polymerized within 6–8 h
and nearly full conversion was eventually reached (Fig. 3A).
Molar masses increased with time and conversion, with
however a significant apparent amount of remaining
macroCTA, and therefore increasing Đ (Fig. 3B). Nevertheless,
particle size increased with conversion and retained a homo-
geneous character (Table S4†). As observed by TEM, pure
spherical NPs were obtained with DPth = 100 at 15 wt%
Fig. 1 RAFT solution polymerization of PBBMA in DMAc at 70 °C. (A)
First-order kinetic plots for various [PBBMA] and DPth. Dashed lines
correspond to linear fits. (B) Evolution of number-average molar mass
(top) and dispersity (bottom) with PBBMA conversion for [PBBMA] = 0.6
M at various DPth. (C) Size-exclusion chromatograms of polymers
obtained at different times for [PBBMA] = 0.6 M and DPth = 100.
Fig. 2 (A) Size-exclusion chromatograms of polymers obtained by
PBBMA emulsion RAFTPISA in water/ethanol 3 : 1 vol/vol at 70 °C with
POEGMA500 at DPth = 100, and 20 wt% solids content (entry 4 from
Table S2†). (B) Transmission electron micrograph of nanoparticles
obtained in the conditions mentioned above, after 2 h.
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(Fig. 3C). Importantly, the hydrodynamic diameters of the NPs
remained essentially unchanged when transferred to water
with no sign of aggregation (Table S4†). At higher target DPth
and/or solids content, PISA syntheses gave more condensed
jelly-like solution or gel sedimentation indicating possible for-
mation of worm-like filomicelles/nanofibers (entries 5, 6, and
9, Table S3†). At higher DPth and solids content, i.e., 200–400
and 30 wt%, control was lost both in terms of MMDs (Đ > 2)
and colloidal stability (precipitation). When POEGMA300 was
replaced with POEGMA500 (Table S5†), kinetics remained
similar (Fig. S14†). For DPth = 100 at 15 wt%, a colloidally
stable dispersion was obtained, however with conversion-
dependent evolution of the dispersion characteristics, follow-
ing classic observations made in PISA formulations leading to
higher-order morphologies: first, fluid dispersions of small
nanoparticles; then, gel with large heterogeneous particle size
distribution (PSD); finally, viscous dispersions with homo-
geneous PSD (Fig. S15 and Table S6†). As of now, we have not
investigated all these samples departing from classic core–
shell spheres in depth, since BNCT has so far typically
required spherical nanoparticles. Nevertheless, note that other
PISA morphologies, particularly anisotropic structures, could
be interesting as well.43
In most dispersion RAFTPISA experiments, the dispersity of
the resulting block copolymers was relatively high, with the
presence of a low-molar-mass tail in MMDs. While this tail is
not uncommon and is typically attributed to a fraction of
residual macroCTA, its relatively high intensity was
puzzling. We and others did not observe this in the RAFTPISA
of BzMA or 2-hydroxypropyl methacrylate with similar
macroCTAs.38,44,45 We postulated that some interactions with
the SEC stationary phase arising from moieties not present in
those previous systems could be responsible for the observed
MMD distortions in the present case. In fact, when we incu-
bated PBBMA in methanol at 70 °C, we found that a steady
amount of free pinacol (13–14 mol%) was instantaneously
formed (Fig. S17†). To investigate this, we added free pinacol
to a dispersion RAFTPISA in order to shift the equilibrium
between boronate ester on the one hand and boronic acid and
pinacol on the other hand towards the former. POEGMA500-
mediated RAFTPISA of PBBMA with pinacol (20 mol% with
regards to PBBMA) was slightly accelerated (Fig. S18A†), with
final nanoparticles very similar in size (see Fig. S19†). More
importantly, SEC analysis of final block copolymer evidenced
narrower MMDs with a noticeable decrease of the aforemen-
tioned tail signal (Fig. S18B†), which is an indirect proof of
possibly interference of hydrolyzed boronate ester moieties
with a neat RAFTPISA. A possible solution to this issue would
be the use of dry methanol.
The motivation of this study being the development of a
potential boron delivery agent for BNCT, we sought to prelimi-
narily assess the biocompatibility of the RAFTPISA-
made POEGMA-b-PPBBMA NPs. For imaging purposes, fluo-
rescent NPs were prepared by adding a small amount of fluor-
escein methacrylate (FMA) to a PISA recipe.46 Briefly, nano-
particles NP1 and NP2, without and with surface functional
groups, respectively, were obtained from POEGMA500 and
POEGMA500NHS, respectively (see ESI†). NHS ester-surface-func-
tionalized NP2 were subsequently reacted with 3-aminophenyl-
boronic acid to produce NP3 with specific targeting agent for
sialylated epitopes (Fig. 4A), as mentioned earlier. Successful
surface modification to obtain NP3 was confirmed by the
appearance of aromatic signals in deuterated polar media, in
which the core is invisible (Fig. S20†). The NP dispersions
were dialyzed against MeOH, then water, to remove unreacted
monomer and switch the dispersant, respectively. Their col-
loidal characteristics in cell culture media are collated in
Table S7.† The fluorescent nature of the NPs was confirmed by
fluorescence spectroscopy with λem,max = 515 nm (Fig. S20†).
Next, we analyzed interactions of the NPs with scavenger
cells. Indeed, clearance by the reticuloendothelial system (RES)
typically accounts for the poor delivery of nanomedicines to
target tissues.47 Therefore, uptake and cytocompatibility of
NP1 and NP3 were tested in RAW 264.7 and HUVEC cells,48
Fig. 3 (A) Conversion vs. time plots for PBBMA dispersion RAFTPISA with POEGMA300 at [AIBN]/[POEGMA300] = 0.5 at various solids contents and
DPth. (B) Size-exclusion chromatograms of polymers obtained by PBBMA dispersion RAFTPISA in methanol at 70 °C with POEGMA300 at [AIBN]/
[POEGMA300] = 0.5, DPth = 100, and 15 wt% solids content (entry 7, Table S3†). (C) Transmission electron micrograph of nanoparticles obtained after
25 h under conditions corresponding to B (entry 7, Table S3†).
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which are widely used as model systems in nanotoxicology and
represent macrophages and endothelial cells, respectively,
belonging to the RES.45 Fluorescein-labeled, carboxylated poly-
styrene (PS-COOH) NPs were included as a reference polymeric
nanomaterial.49 As seen in Fig. 4B, nanoparticles NP1 and NP3
were non-toxic up to the concentration of 100 μg mL−1 over
24 h of exposure. Note that NP1 could not be assessed with
HUVECs because large agglomerates were formed in the
corresponding M200/LSGS cell medium (Table S7†) and inter-
fered with image analysis. Compared to PS-COOH NPs, non-
functionalized NP1 were taken up at very low amounts in
macrophages and adhered to endothelial cells (presumably
due to agglomeration). However, 3-aminophenylboronic acid-
functionalized NP3, intended for targeting selected cells of
interest, did not accumulate in macrophages and endothelial
cells (Fig. S21−S23†). Hence, future investigations on clearance
of these NPs in vivo as well as their potential to target specific
cell types are warranted. The difference in colloidal stability
between NP1 and NP3 in these conditions remains to be eluci-
dated. Nevertheless, functional nanoparticles NP3 appear to
be promising for BNCT.
While their stealth core–shell architecture and their ease of
functionalization with targeting moieties or labels confer deci-
sive advantages over boronophenylalanine (BPA) – the classic
BNCT agent – it is particularly interesting to put into perspec-
tive the “solubilizing effect” of the present NPs with the
maximum solubility of BPA. The latter is indeed soluble at
physiological pH only up to about 6 mg mL−1, that is,
0.031 wt% of boron.50 Considering the best working systems
here (entries 4 and 7 of Tables S2 and S3,† respectively), boron
mass concentrations with one order of magnitude higher are
achieved (0.42 and 0.33 wt%, respectively), within non-opti-
mized systems (see calculations in ESI†). At the same time, the
boron concentration per mass unit of compound remains in
the same range: 5.2 wt% for BPA vs. 2.8 and 2.2 wt%,
respectively.
Conclusions
In this communication, we described for the first time the syn-
thesis of amphiphilic diblock copolymer nanoparticles with a
boron-rich core by polymerization-induced self-assembly
(PISA). A new methacrylic monomer with a pinacol boronate
ester was synthesized with good yields from commercially
available and cheap reagents in two steps. Its efficient RAFT
polymerization was demonstrated for limited degrees of
polymerization, both in homogeneous and heterogeneous
systems. Using hydrophilic macromolecular transfer agents,
PISA could be carried out to obtain sub-100 nm spherical
nanoparticles using both emulsion and dispersion polymeriz-
ation in (hydro)alcoholic media. While they may not be useful
for the envisioned application, i.e., boron-neutron capture
therapy (BCNT), typical PISA higher-order morphologies such
as nanorods/fibers and nano/microvesicles were not investi-
gated, yet could be part of further investigations. Future work
should also be directed to refining the optimal block copoly-
mer composition (DP of 1st block vs. DP of 2nd block) to
increase the relative boron concentration within the nano-
particles. Finally, encouraged by the preliminary results on
biocompatibility reported here, implementation of the new
nanoparticles in BNCT, first in vitro, then possibly in vivo,
should be performed.
Fig. 4 (A) Modification of NHS ester-functionalized POEGMA500NHS-b-PPBBMA nanoparticles. R1 = 4-phenylboronate pinacol ester; R2 = fluor-
escein. i: 3-aminobenzeneboronic acid, triethylamine, ambient temperature. (B) Cell viability of boron-containing PISA-made nanoparticles NP1 and
NP3 in RAW 264.7 cells and HUVECs. Data are representative of 2 independent experiments, each performed in triplicates and shown as means ±
SEM. *Significantly different from control group (*p < 0.05, **p < 0.01).
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